Cosmos Health (NASDAQ:COSM) CEO Acquires $161,332.81 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 701,447 shares of the company’s stock in a transaction on Wednesday, June 10th. The stock was acquired at an average cost of $0.23 per share, for a total transaction of $161,332.81. Following the completion of the transaction, the chief executive officer owned 13,263,361 shares in the company, valued at approximately $3,050,573.03. This trade represents a 5.58% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

Cosmos Health Stock Performance

COSM opened at $0.21 on Friday. The stock has a market cap of $12.79 million, a PE ratio of -0.32 and a beta of 4.79. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31. Cosmos Health Inc. has a 1 year low of $0.20 and a 1 year high of $1.32. The stock’s 50 day simple moving average is $0.31 and its 200-day simple moving average is $0.40.

Cosmos Health (NASDAQ:COSM) last released its quarterly earnings data on Thursday, May 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.06). The business had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%. Sell-side analysts forecast that Cosmos Health Inc. will post -0.06 EPS for the current year.

Institutional Trading of Cosmos Health

A number of institutional investors and hedge funds have recently modified their holdings of COSM. Renaissance Technologies LLC increased its position in shares of Cosmos Health by 260.5% during the fourth quarter. Renaissance Technologies LLC now owns 334,575 shares of the company’s stock valued at $167,000 after purchasing an additional 241,775 shares during the period. Citadel Advisors LLC increased its position in shares of Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock valued at $250,000 after purchasing an additional 128,776 shares during the period. Finally, XTX Topco Ltd increased its position in shares of Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock valued at $50,000 after purchasing an additional 34,117 shares during the period. 12.61% of the stock is currently owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.